Why is Pharmaids Pharma falling/rising?
As of 08-Oct, Pharmaids Pharmaceuticals Ltd's stock price is Rs 49.00, down 6.18%, with a significant decline of 19.65% over the past week and 30.48% year-to-date. The stock is underperforming compared to the Sensex, indicating broader market challenges and a bearish trend.
As of 08-Oct, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 49.00, which reflects a decrease of Rs 3.23 or 6.18%. The stock has been underperforming significantly, having lost 19.65% over the last seven days and showing a 20.33% decline over the past month. Despite opening with a gain of 5.3% today and reaching an intraday high of Rs 55, it ultimately fell to its current low. The stock is trading below all key moving averages, indicating a bearish trend, and has shown high volatility with an intraday fluctuation of 5.77%. Additionally, while there has been a notable increase in investor participation, with delivery volume rising by 572.1% against the five-day average, the overall performance remains weak.In the broader market context, Pharmaids Pharmaceuticals Ltd has significantly underperformed compared to the Sensex, which has gained 0.98% over the past week, while Pharmaids has dropped 14.90%. The year-to-date performance also highlights a stark contrast, with Pharmaids down 30.48% compared to the Sensex's 4.65% increase. This disparity suggests that the stock's recent struggles are not just company-specific but also reflect broader market dynamics where investor sentiment may be shifting away from it. The lack of positive factors in the dashboard further emphasizes the challenges facing the company, contributing to its declining stock price.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
